Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Jay H. Herman"'
Publikováno v:
Critical Care, Vol 22, Iss 1, Pp 1-8 (2018)
Abstract Platelet transfusions carry greater risks of infection, sepsis, and death than any other blood product, owing primarily to bacterial contamination. Many patients may be at particular risk, including critically ill patients in the intensive c
Externí odkaz:
https://doaj.org/article/a849b1c2196f4d8b964576b496d823c4
Publikováno v:
Applied Health Economics and Health Policy. 19:487-499
Technologies used in the processing of whole blood and blood component products, including pathogen reduction, are continuously being adopted into blood transfusion workflows to improve process efficiencies. However, the economic implications of thes
Autor:
Katherine M. Prioli, Ilze Abersone, Patricia M. Kopko, Jay H. Herman, Brian Custer, Laura T. Pizzi
Publikováno v:
Transfusion. 62(2)
Bloodborne pathogens pose a major safety risk in transfusion medicine. To mitigate the risk of bacterial contamination in platelet units, FDA issues updated guidance materials on various bacterial risk control strategies (BRCS). This analysis present
Publikováno v:
The American Journal of Case Reports
Case series Patients: Female, 68 • Male, 86 Final Diagnosis: Acute hypotensive transfusion reaction Symptoms: Hypotension Medication: — Clinical Procedure: — Specialty: Anesthesiology Objective: Challenging differential diagnosis Background: Ac
Publikováno v:
Applied Health Economics and Health Policy
Background US FDA draft guidance includes pathogen reduction (PR) or secondary rapid bacterial testing (RT) in its recommendations for mitigating risk of platelet component (PC) bacterial contamination. An interactive budget impact model was created
Autor:
Susan M. Dasovich, Johannes Ledolter, Eric S. Schwenk, Richard H. Epstein, Franklin Dexter, Jay H. Herman, Joni M. Maga
Publikováno v:
Anesthesia & Analgesia. 126:1654-1661
Hospitals review allogeneic red blood cell (RBC) transfusions for appropriateness. Audit criteria have been published that apply to 5 common procedures. We expanded on this work to study the management decision of selecting which cases involving tran
Publikováno v:
Immunohematology. 34:93-97
The inherent tradeoff between sensitivity and specificity in the detection of unexplained antibodies has been the objective of many studies, editorials, and journal articles. Many publications note that no method is capable of detecting all clinicall
Publikováno v:
Clinica Chimica Acta. 474:124-129
Background A model for hemoglobin A1c (HbA1c) formation was used to predict the relationship between average glucose (AG) and %HbA1c under conditions of altered red blood cell lifetime (RCL). Methods Using a kinetic mass balance model for formation o
Publikováno v:
Applied health economics and health policy. 17(2)
This reply refers to the article available at https://doi.org/10.1007/s40258-018-0409-3 .
Publikováno v:
Transfusion. 56:2368-2373
BACKGROUND Prosthetic hip–associated cobalt toxicity (PHACT) is an uncommon, but potentially devastating, complication for patients with metal-on-metal hip implants (MoMs). Clinical management of PHACT is poorly defined, with primary intervention b